{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy",
    "Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Letizia Matera"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Julian David Etessami"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Carmine Valenza"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Giuseppe Curigliano"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7cdzxbfcxk4gw.bib",
  "cited_by": 0,
  "doi": "10.1080/14796694.2026.2742759",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757669/",
  "id": "7cdzxbfcxk4gw",
  "issns": [
    "1479-6694",
    "1744-8301"
  ],
  "landing_url": "https://doi.org/10.1080/14796694.2026.2742759",
  "language": "en",
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Drug Evaluation"
    ],
    [
      "heading",
      "Review Article"
    ],
    [
      "openalex",
      "2730|Advanced Breast Cancer Therapies"
    ]
  ],
  "openalex": "W7220433626",
  "pdf_url": null,
  "pmcid": "PMC13757669",
  "pmid": "42831391",
  "published": "2026-10-05",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/7cdzxbfcxk4gw.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:15Z",
      "native_id": "PMC13757669",
      "source": "pmc",
      "url": "https://doi.org/10.1080/14796694.2026.2742759"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Advanced Breast Cancer Therapies",
      "subfield": "oncology"
    }
  ],
  "title": "Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective",
  "title_text": "Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:15Z",
  "url": "https://research.draconitic.com/paper/7cdzxbfcxk4gw",
  "venue": "Future Oncology",
  "versions": []
}